1st or 2nd Line MBC (Metastatic Breast Cancer) With Previous Avastin (Bevacizumab) Therapy
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Clifford A Hudis, MD
Memorial Sloan Kettering Cancer Center
Study Chair - Lee S Schwartzberg, MD, FACP
Accelerated Community Oncology Research Network Inc
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
44 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Providence Cancer Center / Katmai Oncology Group Llc
Anchorage, Alaska, United States
- Highlands Oncology Group
Fayetteville, Arkansas, United States
- Compassionate Cancer Care-Corona
Corona, California, United States
- Compassionate Cancer Care-Fountain Valley
Fountain Valley, California, United States
- California Cancer Care
Greenbrae, California, United States
- Long Beach Memorial Medical Center
Long Beach, California, United States
- Compassionate Cancer Care-Riverside
Riverside, California, United States
- Sutter Cancer Center
Sacramento, California, United States
- California Pacific Medical Center
San Francisco, California, United States
- University of California San Francisco Comprehensive Cancer Center
San Francisco, California, United States
- Front Range Cancer Specialists
Fort Collins, Colorado, United States
- Hematology Oncology Pc / Bennett Cancer Center
Stamford, Connecticut, United States
- Oncology Associates of Bridgeport
Trumbull, Connecticut, United States
- Georgetown University Medical Center
Washington D.C., District of Columbia, United States
- Washington Cancer Institute
Washington D.C., District of Columbia, United States
- Pasco Hernando Oncology Associates Pa
Brooksville, Florida, United States
- Pasco Hernando Oncology Associates Pa
New Port Richey, Florida, United States
- Augusta Oncology Associates, Pc
Augusta, Georgia, United States
- Cascade Cancer Center
Macon, Georgia, United States
- Central Georgia Cancer Care
Macon, Georgia, United States
- Northwest Georgia Oncology Center
Marietta, Georgia, United States
- Northwestern University-Robert H. Lurie Comprehensive Cancer Center
Chicago, Illinois, United States
- Rush University Medical Center
Chicago, Illinois, United States
- Ingalls Memorial Hospital
Harvey, Illinois, United States
- Quincy Medical Group
Quincy, Illinois, United States
- Northern Indiana Cancer Research Consortium
South Bend, Indiana, United States
- Mary Bird Perkins Cancer Center
Baton Rouge, Louisiana, United States
- Maine Center for Cancer Medicine
Scarborough, Maine, United States
- Boston Medical Center
Boston, Massachusetts, United States
- Baystate Medical Center
Springfield, Massachusetts, United States
- University of Michigan Comprehensive Cancer Center
Ann Arbor, Michigan, United States
- Columbia Comprehensive Cancer Care Clinic & Research Institute
Jefferson City, Missouri, United States
- Oncology Hematology Specialists, Pa
Denville, New Jersey, United States
- Roswell Park Cancer Institute
Buffalo, New York, United States
- Hematology Oncology Associates of New York
East Syracuse, New York, United States
- Queens Cancer Center
Jamaica, New York, United States
- Memorial Sloan-Kettering Cancer Center
New York, New York, United States
- Presbyterian Hospital
Charlotte, North Carolina, United States
- North Coast Cancer Care
Sandusky, Ohio, United States
- Hematology Oncology of Northeast Pennsylvania
Dunmore, Pennsylvania, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Jun 2007
- Primary completion
- 30 Sept 2010
- Completion
- 30 Nov 2012
- Last update posted
- 20 May 2014
- Registered enrollment
- 160
- Registry id
- NCT00493636
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.